Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products > 77 > 

77-21-4

Products Categories

Basic Information
CAS No.: 77-21-4
Name: DL-Glutethimide
Article Data: 17
Molecular Structure:
Molecular Structure of 77-21-4 (DL-Glutethimide)
Formula: C13H15 N O2
Molecular Weight: 217.268
Synonyms: Glutarimide,2-ethyl-2-phenyl- (7CI,8CI); (?à)-2-Ethyl-2-phenylglutarimide; (?à)-3-Ethyl-3-phenyl-2,6-piperidinedione; (?à)-Glutethimide;2-Ethyl-2-phenylglutarimide; 2-Phenyl-2-ethylglutaric acid imide;3-Ethyl-3-phenyl-2,6-diketopiperidine; 3-Ethyl-3-phenyl-2,6-dioxopiperidine;3-Ethyl-3-phenyl-2,6-piperidinedione; 3-Ethyl-3-phenylglutarimide;3-Phenyl-3-ethyl-2,6-diketopiperidine; 3-Phenyl-3-ethyl-2,6-dioxopiperidine;Doriden; Doriden-Sed; Elrodorm; Glimid; Glutethimid; Glutethimide; Glutetimid;NSC 95239; Noxiron; Noxyron; Rigenox; Sarodormin; a-Ethyl-a-phenylglutarimide; a-Phenyl-a-ethylglutaricacid imide; a-Phenyl-a-ethylglutarimide
EINECS: 201-012-0
Density: 1.11 g/cm3
Melting Point: 84°C
Boiling Point: 393.5 °C at 760 mmHg
Flash Point: 161.8 °C
Solubility: 0.95g/L(27 oC)
Appearance: White crystalline powder.
Hazard Symbols: Xn,T,F
Risk Codes: 22-39/23/24/25-23/24/25-11
Safety: Poison by ingestion and intraperitoneal routes. Human systemic effects by ingestion: pupillary dilation, ataxia, somnolence, coma, and blood pressure depression. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. Caution: May be habit forming. This is a controlled substance (depressant) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.13 (1985).
PSA: 46.17000
LogP: 2.09980
Downstream Products
125-84-8
  • Display:default sort

    New supplier

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

Chemistry

Glutethimide(77-21-4)'s molecular formula is C13H15NO2 and its formula weight is 217.26.
Glutethimide(77-21-4) has a  melting point of 103-104°C.
The molecular structure of Glutethimide(77-21-4):

History

Glutethimide(77-21-4) is a hypnotic sedative that was introduced in 1954 as a safe alternative to barbiturates to treat insomnia. Before long, however, it had become clear that glutethimide(77-21-4) was just as likely to cause addiction and caused similarly severe withdrawal symptoms. Doriden is the brand-name version of the drug; both the generic and brand-name forms are rarely prescribed today.

Toxicity Data With Reference

1.   

orl-chd TDLo:25 mg/kg:CNS

   AJDCAI    American Journal of Diseases of Children. 130 (1976),507.
2.   

orl-hmn TDLo:171 mg/kg

   JAMAAP    JAMA, Journal of the American Medical Association. 214 (1970),1704.
3.   

unr-man LDLo:147 mg/kg

   85DCAI    Poisoning; Toxicology, Symptoms, Treatments. 2 (1970),73.
4.   

orl-rat LD50:600 mg/kg

   27ZQAG    Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,233.
5.   

orl-mus LD50:360 mg/kg

   27ZQAG    Psychotropic Drugs and Related Compounds E. Usdin andD.H. Efron,2nd ed.,Washington, DC.: 1972,233.
6.   

ipr-mus LD50:208 mg/kg

   APPHAX    Acta Poloniae Pharmaceutica. 32 (1975),243.
7.   

orl-dog LD50:500 mg/kg

   SMWOAS    Schweizerische Medizinische Wochenschrift. 85 (1955),305.
8.   

orl-mky LDLo:300 mg/kg

   TXAPA9    Toxicology and Applied Pharmacology. 29 (1974),75.

Consensus Reports

EPA Genetic Toxicology Program.

Safety Profile

Poison by ingestion and intraperitoneal routes. Human systemic effects by ingestion: pupillary dilation, ataxia, somnolence, coma, and blood pressure depression. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx. Caution: May be habit forming. This is a controlled substance (depressant) listed in the U.S. Code of Federal Regulations, Title 21 Part 1308.13 (1985).

Specification

Legal status
Glutethimide(77-21-4) is a Schedule II drug under the Convention on Psychotropic Substances. It was originally a Schedule III drug in the United States under the Controlled Substances Act, but in 1991 it was upgraded to Schedule II, more than a decade after recreational abusers discovered that combining the drug with codeine produced a euphoria which closely resembles that obtained from heroin.
A question has appeared on the DABT examination on Glutethimide(77-21-4).